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Summary
Objectives: Splenic abscess is an uncommon disease, with a reported incidence of 0.14—0.7% in
autoptic series. The best treatment option remains unclear. We report our experience of
percutaneous drainage of splenic abscess under ultrasound (US) guidance.
Methods: From 1979 to 2005, 16 consecutive patients (12 male and four female; mean age 39.9
years, range 16—72 years) were diagnosed with splenic abscess by means of US, and were treated
with medical therapy alone or combined with US-guided percutaneous aspiration or catheter
drainage.
Results: Ten of 16 patients had bacterial abscesses (including one case of tubercular abscess),
two had an amebic abscess, and four had fungal abscesses. Seven of ten patients with bacterial
abscesses were successfully treated with fine needle aspiration alone, one patient was success-
fully treated with fine needle aspiration for one abscess and catheter drainage for another, and
one patient, who subsequently required a splenectomy for an abdominal trauma, successfully
underwent percutaneous catheter drainage alone. Four patients with fungal lesions were treated
with medical therapy alone, and two patients later required a splenectomy. One patient with a
bacterial abscess due to endocarditis was treated with medical therapy alone, and his recovery
was uneventful.
Conclusions: US-guided percutaneous aspiration of splenic abscesses is a safe and effective
procedure. It can be used as a bridge to surgery in patients who are critically ill or have several
comorbidities. Percutaneous aspiration may allow complete non-operative healing of splenic
abscesses or temporize patients at risk for surgery.
# 2008 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Splenic abscess is an uncommon disease, with a reported
incidence of 0.14—0.7% in autoptic series.1 It has been
reported that 70% develop in patients with concurrent infec-
tions.2 In recent years, splenic abscesses have been diag-
nosed more frequently owing to the increased number of
immunocompromised patients,3—6 who are particularly at
risk for this disease, and the widespread use of diagnostic
imaging modalities such as computed tomography (CT) and
ultrasonography (US). US plays a valuable role due to its
advantages of safety, repeatability, diagnostic accuracy, ease
of bedside use, and low cost. In the diagnosis of splenic
abscesses, the sensitivity of US is up to 90%.7,8
The management of splenic abscesses is based on medical
therapy with antibiotics and surgery or percutaneous drai-
nage.9—17 The best treatment option remains unclear. While
it is recognized that percutaneous drainage may be appro-
priate for some patients initially, the high failure rate (14.3—
75%) reported in the literature demonstrates that surgery
still remains the standard treatment.3—6,9—11
The purposes of this study were to analyze the relevant
clinical aspects of splenic abscesses in our series and to
report our experience with US-guided percutaneous drainage
of splenic abscesses.
Patients and methods
Patients
The data of patients admitted to our division of infectious
and tropical diseases between November 1979 and August
2005 were retrospectively collected. The medical files of 16
consecutive patients (12 male and four female; mean age
39.9 years, range 16—72 years) diagnosed with splenic
abscess were retrieved. The diagnosis of splenic abscess
was made by US alone in five patients, and by US and CT
in 11 patients. Arteriography was required by the surgeon in
two of the three patients who underwent splenectomy. In all
patients, a chest radiograph was also obtained.
Methods
Patient presentation on admission and underlying patholo-
gies were recorded. Size, number, and US features of the
abscesses were determined.
Laboratory methods
Cultures of blood from peripheral veins were performed with
the BACTEC system (BACTEC 9240, Becton Dickinson, Italy)
with BACTEC PLUS Aerobic/F and PLUS Anaerobic/F culture
vials. Exudates collected from abscesses were inoculated on
routine agars and incubated in a moist atmosphere of 5% CO2
at 35 8C for 48 h and on anaerobic media incubated in an
anaerobic atmosphere for 72 h. The microorganisms isolated
were identified on the basis of Gram stain and biochemical,
enzymatic, and sugar fermentation characteristics. Suscept-
ibility tests were performed by the disk diffusion method on
Mueller—Hinton agar with 24 h of incubation at 35 8C. The
results were expressed as susceptible, intermediate, or
resistant according to the criteria of the Clinical and Labora-tory Standards Institute (M100-S17, 2007) for the modified
Kirby—Bauer method.
The remaining part of the specimenwas streaked onto two
Petri plates of Sabouraud dextrose agar plus chloramphenicol
(Oxoid SpA, Italy) for isolation of fungi, one incubated at
25 8C and one at 30 8C for 3 weeks. A slide culture performed
by the Riddell technique showed the fungal morphological
characteristics.
Primary mycobacterial isolation was performed by means
of Lowenstein—Jensen medium and BBL MGIT medium (BAC-
TEC MGIT 960 system, Becton Dickinson, Italy) using standard
laboratory techniques. Biochemical identification of Myco-
bacterium tuberculosis complex isolates was assessed by
niacin production and results were subsequently confirmed
by the use of DNA probes (Gene Probe hybridization assay,
Biomerieux, France). Susceptibility testing was carried out
according to the standard variation of the proportion
method.
Fresh specimens were collected for the recovery of para-
sitic organisms. Results obtained by microscopic examination
of wet smears were confirmed by permanent stained smears.
Serologic examination for Entamoeba histolytica was per-
formed with indirect hemagglutination antibody assay.
Percutaneous treatments
In all patients, a freehand US-guided fine needle diagnostic
aspiration was performed before any treatment to obtain a
microbiologic diagnosis and to evaluate the physical aspect of
the abscess fluid. Blood and pus cultures for aerobes, anae-
robes, mycobacteria, and fungi were carried out.
US-guided fine needle aspiration was the first line treat-
ment in patients with pyogenic or amebic abscesses unless
the lesion was peripherally located. In that case, percuta-
neous US-guided catheter drainage was the preferred choice.
Patients with fungal abscesses were treated with medical
therapy alone.
Coagulation status was assessed before the procedure.
The following values were considered acceptable: a pro-
thrombin time of less than 15 s, a partial thromboplastin
time of less than 42 s, an international normalized ratio
(INR) of less than 1.8, and a platelet count greater than
50  109/l.
During the puncture, patients were asked to limit respira-
tory excursion to a minimum to avoid tearing of the splenic
parenchyma. All procedures were carried out under real-
time US guidance using either an AU940 or AU450 real-time
scanner (Esaote Biomedica, Genoa, Italy) with 3.5 MHz
curved-array and 5.0 MHz linear array transducers. Thera-
peutic US-guided aspiration was done using an 18- or 20-G
20 cm long needle (Ecojekt, modified Chiba needle, Hospital
Service, Hakko Shoji, Japan) under local anesthesia with
10 ml of lidocaine hydrochloride 2% (Lidocaina, Molteni,
Italy). The one-step technique was used for placing the
drainage catheters. A 5—7 F standard pigtail was inserted.
The catheter was removed when there was no draining fluid
for 24 hours and abscess resolution was confirmed on ima-
ging. All percutaneous treatments were performed by the
same experienced operator (CF).
After the aspiration, rifampin (Rifadin, Lepetit, Milan,
Italy) or metronidazole (Deflamon, Spa, Milan, Italy) was
injected into the lesion, in a quantity of about half the
volume of the drained pus. A thorough US examination was
Table 2 Clinical findings on admission in 16 patients with
splenic abscess.
Symptoms and signs No.
Fever 15/16 (93.8%)
Abdominal pain 13/16 (81.3%)
Palpable splenomegaly 7/16 (43.8%)
Abdominal mass 2/16 (12.5%)
Chest X-ray abnormalities a 9/16 (56.3%)
Leukocytosis >13  109 cells/l 10/16 (62.5%)
a Left pleural effusion, atelectasis of left lung lower lobe, and
elevated left hemidiaphragm.
Table 1 Demographics, management, and outcomes of 16 patients with splenic abscesses.
Case No. Sex Age Predisposing factors No. of
abscesses
Abscess
size (cm)a
Treatment Outcome
1 F 16 Post surgical sepsis 1 6.3 FNA (5) Recovered
2 M 37 Abdominal trauma 1 7.2 CD + splenectomy Recovered
3 M 72 Leukemia 1 4.5 FNA (4) Died after
26 days for leukemia
4 M 27 AIDS 2 5.0; 1.8 FNA on 5 cm lesion (2) Recovered/
died after 8 month
5 M 25 AIDS 3 2.0; 2.4; 3.5 FNA (1; 1; 1) Recovered/
died after 5 month
6 F 23 Staphylococcal endocarditis
in drug addict
2 3.5; 4.2 FNA on 3.5 cm lesion (1);
CD on 4.2 cm lesion
Recovered
7 F 63 Travel to Africa;
amebic enteritis;
breast cancer
1 6.8 FNA (2) Recovered
8 F 22 Travel to Africa;
amebic enteritis;
alcoholism;
drug addiction
1 5.4 FNA (3) Recovered
9 M 46 Psychopathology; alcoholism;
abdominal trauma
1 6.0 FNA (3) Recovered
10 M 64 Lymphoma 1 5.6 Medical therapy Died after 13 months
11 M 28 AIDS 3 1.5; 1.7; 2.0 Medical therapy Recovered
12 M 35 AIDS 1 4.5 FNA (1) Recovered
13 M 53 Underlying acute myeloid
leukemia; mycotic
endocarditis
multiple 4.5; 2.5 Medical therapy +
splenectomy
Died after 3 months
14 M 29 Acute myeloid leukemia multiple 3.1 Medical therapy +
splenectomy
Died
15 M 40 AIDS 1 2.8 FNA (1) Recovered
16 M 59 Endocarditis 1 3.8 Antibiotics Recovered
FNA, fine needle aspiration; CD, catheter drainage. Figures in parenthesis are number of fine needle aspirations performed; in cases with
multiple abscesses the number of fine needle aspirations performed for each one is separated by a semicolon.
a In cases with multiple abscesses a semicolon separates the size of each one.
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Pending results of pus and blood cultures, intravenous broad-
spectrum antibiotics, such as second- or third-generation
cephalosporins, gentamicin, and quinolones, were adminis-
tered. Afterwards, the most effective antibiotics chosen on
the basis of antibiograms were given. In patients with nega-
tive cultures but purulent material on visual inspection and a
cytological diagnosis of an abscess, broad-spectrum antibio-
tic therapy was continued. The patients were discharged
from the hospital when fever, clinical signs, and imaging
findings disappeared.
Patient outcomes, including procedure-related complica-
tions, treatment failure, and death, were recorded. The
follow-up was based on US and clinical examinations per-
formed in all patients every 3 days in the first month, and
then monthly over 6 months.
Results
Patient presentation on admission
Patient characteristics, including age, sex, predisposing fac-
tors, and number and size of splenic abscesses are shown in
Table 1. The most important signs and symptoms are shown inTable 2. Ten of 16 patients (62.5%) had a white cell count over
13  109 cells/l (range 2.2—39  109/l, mean 14.673  109/
l). Abnormalities of the chest radiograph were found in nine
(56.3%): left pleural effusion in three patients (18.8%),
atelectasis of the left lung lower lobe in two patients
(12.5%), and elevated left hemidiaphragm in four patients
(25%).
In three patients the liver and the brain were also
affected, and in one patient the abscess also involved the
Table 3 Splenic abscess causative pathogens.
Case No. Etiology Pus culture Blood culture
1 Bacterial Streptococcus/Bacteroides fragilis/coccobacillus Positive for Staphylococcus
2 Bacterial Proteus spp Proteus spp
3 Bacterial Staphylococcus aureus Negative
4 Bacterial Negative Negative
5 Bacterial Escherichia coli/Klebsiella Positive for Escherichia coli
6 Bacterial Staphylococcus aureus Staphylococcus aureus
7 Amebic Negative Negative
8 Amebic Negative Negative
9 Bacterial Staphylococcus aureus/Peptostreptococcus Positive for Staphylococcus
10 Fungal Aspergillus spp Negative
11 Fungal Aspergillus spp Negative
12 Bacterial Multiple pathogens Multiple pathogens
13 Fungal Candida glabrata Candida glabrata
14 Fungal Aspergillus spp Negative
15 Bacterial Mycobacterium tuberculosis Negative
16 Bacterial N/A Viridans Streptococcus
N/A, not available.
Management of splenic abscess 527diaphragm, the tail of the pancreas, and the left adrenal
gland. All patients had acceptable coagulation parameters.
Causative agents
The etiology of the splenic abscess was bacterial in 10 of 16
cases (62.5%), amebic in two (12.5%), and fungal in the
remaining four (25%) (Table 3). No abscess was secondary
to hydatid disease. Blood culture was positive in eight of 16
(50%) cases. Fine needle aspiration was performed as a
diagnostic procedure in 15 of the 16 patients (93.7%). Pus
culture was positive in 12 of 15 (80%) patients who underwent
diagnostic fine needle aspiration, and was polymicrobial in
four of nine (44.4%) aspirated bacterial abscesses.
Blood cultures were negative in both patients with amebic
abscess, and positive in only one of the four cases of fungalFigure 1 Bacterial abscess. The ultrasound scan shows a
hypoechoic, ill-defined bilobate lesion in the lower third of
the spleen.abscess. Pus cultures were positive in eight of the nine
aspirated bacterial abscesses (88.9%) and Staphylococcus
aureus was the more frequently isolated agent (n = 3).
In the two cases of amebic abscess, pus culture did not
yield E. histolytica and diagnosis was based on epidemiolo-
gical data, the anchovy paste appearance of the pus, the
increase in serological titers for E. histolytica, and demon-
stration of the parasite in stools.
In the four cases of fungal abscess, the fluid aspirated from
the lesion grew Aspergillus spp (n = 3) and Candida spp
(n = 1).
Sonographic features of the abscesses
Ten of 16 patients had a single abscess (62.5%) and six had
multiple splenic abscesses (37.5%). Two of 16 patients (12.5%)
had a multiloculated abscess.
Bacterial and amebic abscesses appeared as hypoechoic,
poorly defined round lesions with low level echoes in themost
dependent part, with amebic abscesses showing on average a
larger size (Figures 1 and 2). Fungal abscesses larger thanFigure 2 Amebic abscess. The ultrasound scan of the spleen
shows a large hypoechoic mass in the upper pole.
Figure 3 Fungal abscess. A longitudinal ultrasound scan shows
multiple round, hypoechoic lesions in the spleen parenchyma.
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while smaller (less than 4 cm) lesions were round, smooth
hypoechoic lesions (Figure 3).
Bacterial abscesses were single in seven of 10 (70%) cases;
the size ranged from 1.8 to 7.2 cm (mean 3.0 cm). The
amebic abscesses were both single; diameters were 5.4 cm
and 6.8 cm. Fungal abscesses were multiple in all but one
case; size ranged from 1.5 to 5.6 cm (mean 3.0 cm).
Percutaneous treatments
All but one of 12 patients with bacterial and amebic abscesses
were treated by percutaneous US-guided fine needle aspira-
tion or catheter drainage, whereas medical therapy was the
only treatment in all four cases of fungal abscess. Patient 16,
who suffered from endocarditis and had a splenic bacterial
abscess due to viridans Streptococcus, which was poorly
defined on imaging, was treated with medical therapy alone
and fully recovered after 3 weeks.
Fine needle aspiration alone was performed in nine
(81.8%) of the 11 patients treated percutaneously, and cathe-
ter drainage in two (18.2%). The interval between each fine
needle aspiration was 3—5 days. Catheter drainage was
performed only in case 2 and case 6, in whom surgery would
likely be required. The catheter was left in situ for 12 hours in
case 2 who required surgery because of abdominal trauma,
and for five days in case 6, who made a full recovery without
surgery. In none of the 11 patients treated percutaneously
was open surgical drainage required. No patient required
conscious sedation. A splenectomy was later required in
three patients, two with fungal abscesses and one with a
bacterial abscess. Acute necrotizing pancreatitis required
surgery 24 hours after a 5-F catheter placement in patient
2 who had a splenic bacterial abscess (Proteus spp) treated
with catheter drainage after a wide-impact blunt abdominal
trauma. The surgeon also performed the splenectomy
because of impending spleen rupture. At surgery the abscess
had been completely evacuated with catheter drainage.
Patient 14 with leukemia and fungal abscesses due to
Aspergillus spp required splenectomy after 2 weeks because
of no response to treatment, and died during the intervention.Patient 13, who had a fungal endocarditis due to Candida
glabrata, required splenectomy after 4 weeks because of
underlying acute myeloid leukemia, and he died 3 months
later.
One of the AIDS patients had an abscess that was shown to
be tubercular on microscopic examination. He was treated
with fine needle aspiration of the splenic abscess and anti-
tubercular treatment. The spleen with its crucial immuno-
logical role was thus preserved. Surgery was obviated in ten
of the eleven patients treated percutaneously. Hospital stay
ranged from 3 to 34 days (mean 14 days).
Complications
No procedure-related major complications occurred. The
only minor complication was mild pain in three (33.3%) of
the nine patients treated with fine needle aspiration and in
the two (100%) patients treated with catheter drainage.
During hospitalization, two patients needed total parenteral
nutrition and four required intensive care, with intravenous
administration of immunoglobulins and external mechanical
ventilation support.
Follow-up
US follow-up showed complete resolution of the lesions in
nine cases, while in patient 3 and patient 11 only a reduction
of size was obtained. Six patients died because of the under-
lying disease.
Discussion
Splenic abscess is a rare disease that occurs more often in
males and in immunocompromised patients.3,5,6 In the pre-
antibiotic era splenic abscess was mainly related to typhoid
fever; nowadays the most frequent cause is AIDS followed by
abdominal infections, pneumonia, bacterial endocarditis,
and urogenital infections.18 The rise in international travel
accounts for parasitic abscesses, whereas the increased
number of AIDS patients, and of subjects undergoing organ
transplantation or affected by neoplastic diseases, might
explain the rise in fungal abscesses.4—6,19 In our series,
75% of subjects were male and more than 50% were immu-
nosuppressed. These findings are in accordance with litera-
ture data. Fungal abscesses were observed in patients with
AIDS (n = 1) or malignancies (n = 3).
Diagnostic fine needle aspiration of splenic abscesses is
crucial to choose the most active antibiotics. Indeed,
whereas blood culture isolates are generally monomicrobial,
pus cultures from splenic abscesses are polymicrobial in
almost half the cases. Therefore, clinical samples should
be obtained from both blood and abscess. In immunocom-
promised patients, fine needle aspiration may also help in
differentiating splenic abscesses from other splenic lesions
that have the same appearance on imaging, such as lym-
phoma,metastasis, infarction, or hematoma. Moreover, sple-
nic abscesses caused by disseminated fungal infections may
be unrecognized in patients with AIDS who have life-threa-
tening systemic illnesses.20
Although antibiotics and splenectomy are traditionally
considered the treatment of choice, in a few studies
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guided drainage is favored.12,14 Percutaneous US- or CT-
guided drainage for single abscesses and splenectomy for
multiple abscesses are reported as safe and effective treat-
ment choices.9 The advantages of percutaneous drainage
over surgical drainage are the low risk of intra-abdominal
spreading, the absence of postoperative complications,
including those due to anesthesia or wound infection, a
shorter hospitalization time, lower costs, and better com-
pliance of patients. We treated only two cases with catheter
drainage. We relied on our experience with liver abscess
drainage because spleen abscesses are a rarity and no general
rules have been reported for these in the literature. In liver
abscesses, fine needle aspiration under US guidance is an
effective and low-cost procedure, and is more acceptable to
patients.
Splenectomy entails the risk of fulminant and potentially
life-threatening infection. The most common pathogen is
Streptococcus pneumoniae, but Haemophilus influenzae
and Neisseria meningitidis have also been reported. In a
recent review of the literature, the incidence of infection
after splenectomy was 3.2% and the mortality rate 1.4%.21
Although administration of pneumococcal vaccine and anti-
microbial prophylaxis22 have reduced the infection rate and
mortality, no prophylactic regimen will eliminate the risk of
sepsis.23 Most infections occur within the first 2 years after
splenectomy, but up to a third arise at least 5 years later and
cases of fulminating infections have been reportedmore than
20 years after surgery.24 Although difficult to quantify, the
risk of dying of a serious infection remains clinically signifi-
cant (38—69% of individuals developing post-splenectomy
sepsis will die22) and almost certainly lifelong.21
Splenic abscess is a rare entity that remains mainly a
subject of case reports. The largest series of splenic
abscesses reported in the literature is that of Chang et al.6
They analyzed 67 cases of splenic abscess observed over a
period of 19 years. In their series, Klebsiella pneumoniaewas
the most frequently encountered pathogen, similar to obser-
vations in other Asian countries. Percutaneous drainage or
aspiration was performed in 21 patients (31.3%), and the
mortality rate in this group was 28.6%. In the series of Zerem
and Bergsland, 37 patients with splenic abscess were treated
with percutaneous fine needle aspiration or catheter drai-
nage.17 Fine needle aspiration was performed in 19 patients
and eight of them required percutaneous drainage because of
abscess recurrence. In the 29 cases observed by Chiang et al.,
percutaneous drainage was performed in only two, and it was
successful in both.25
Percutaneous drainage is reported to be a reliable tech-
nique with a high therapeutic success rate and low costs
compared to surgery.12,14,15 Obvious advantages of percu-
taneous drainage are a more rapid and less traumatic pro-
cedure than surgical drainage. The usefulness is even more
substantial for large amebic abscesses, in which the drai-
nage is an emergency maneuver. Independently from the
etiological agent, introducing antibacterial and antiamebic
drugs at a high concentration directly into the abscess cavity
might accelerate healing. Percutaneous image-guided
catheter drainage of splenic abscesses is usually favored
over fine needle aspiration. In the series of Thanos and co-
workers14 all seven patients were treatedwith percutaneous
CT-guided drainage. In our series, we performed fine needleaspiration under US guidance as the first-line treatment and
the procedure was successful in eight of nine patients
(88.9%).
Multiloculated abscesses with thick septations or necrotic
debris respond less favorably to percutaneous drainage and
attempts to increase the success rate of percutaneous drai-
nage by using intracavitary fibrinolytic agents have been
described.26 In our series we observed only two cases of
multiloculated splenic abscess, and they were effectively
treated with percutaneous fine needle aspiration.
The risk of bleeding and damage to adjacent organs should
be taken into account. Hemorrhage is the most common
complication.27 Other complications include pneu-
mothorax,27 pleural effusion, and colonic injury.28 In our
series, no major complications and no mortality related to
the procedure were observed.
Percutaneous drainage of splenic abscess under US gui-
dance is an operator-dependent technique that requires a
high level of skill and experience. Furthermore, when per-
forming the maneuvre it is advisable to have a standby
operating room because of the risk of bleeding.
In conclusion, based on our experience and literature
data, sonographically-guided percutaneous aspiration of
splenic abscesses is a safe and effective procedure. It can
be used as a bridge to surgery in patients who are critically ill
or have several co-morbidities. Percutaneous aspiration may
allow complete non-operative healing of splenic abscesses or
temporize patients at risk for surgery.
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